Abstract:BackgroundDyslipidemia is one of the four major risk factors for the development of cardiovascular disease, along with hypertension, smoking, and diabetic mellitus. This countrywide study aimed to determine the prevalence and patterns of dyslipidemia and to describe their characteristics using data from the Korean population visiting local clinics.MethodsWe retrospectively reviewed the lipid profiles (total cholesterol (TC), low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC), and triglycerides (TG)) and fasting plasma glucose (FPG) test results from Korean patients visiting local clinics during December 2023. Dyslipidemia was defined as having one or more of TC ≥200 mg/dl, LDLC ≥100 mg/dl, HDLC <40 mg/dl for males and <50 mg/dl for females, or TG ≥150 mg/dl (National Cholesterol Education Program, Adult Training Program III, 2002). Glucose levels are considered hyperglycemic if blood glucose ≥126 mg/dl. The subjects comprised 1,232 patients who visited 57 local clinics nationwide were included. Lipid profile tests (except LDLC) and FPG were performed on Hitachi008AS automatic biochemistry analyzer and the LDLC test was calculated by the Friedewald equation. Data for TG ≥400 mg/dL were excluded.ResultsThe study subject population comprised 610 males and 622 females aged 2 to 91 years. The overall prevalence of dyslipidemia was 53.3% (657/1,232), with 49.3% (301/657) males and 57.2 (356/657) females (p<0.001). TC, LDLC, and TG were high in 14.5% (95/657), 33.9% (184/657), and 23.6% (223/657) of patients, respectively; HDLC was low in 28.0% (155/657). The prevalence of dyslipidemia by age group was as follows: 2 to 19 years (36.4%, 4/11); 20 to 29 years (66.7%, 12/18); 30 to 39 years (52.5%, 52/99); 40 to 49 years (61.5%, 131/213); 50 to 59 years (57.0%, 167/293); 60 to 69 years (50.1%, 168/335); 70 to 79 years (48.4%, 91/188); 80 years or older, (42.7%, 32/75). There was a difference in the prevalence of dyslipidemia between the age group under 50 and the age group over 50 (p<0.001). The prevalence of dyslipidemia among males and females was TC (72.6% vs 28.4%), HDLC (55.4% vs 44.6%), LDLC (53.8% vs 46.2%), TG (42.6% vs 57.4%), respectively (p<0.001). Thirteen of the 1,232 patients had dyslipidemia accompanied by hyperglycemia. Seven of them had mixed dyslipidemia (including raised TC, LDLC, and TG (n=4), raised TG & Low HDLC (n=2), raised TC and LDLC (n=1)).ConclusionsThe prevalence of dyslipidemia in Korean patients visiting local clinics was 53.3% and differed by gender, age group, and lipid profile. Considering that the prevalence of dyslipidemia is higher in diabetic patients compared to patients without diabetes, additional studies targeting a large number of patients are needed to promote disease prevention and control.

Characteristics of factor V and protein C based on results from Korean testing centers

Polymorphisms in the Genes for Coagulation Factor II, V, VII in Patients Undergoing Coronary Angiography

Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey

Normal Ranges And Genetic Variants Of Antithrombin, Protein C And Protein S In The General Chinese Population. Results Of The Chinese Hemostasis Investigation On Natural Anticoagulants Study I Group

Current status of testing intervals for antiphospholipid syndrome testing: a 13-year retrospective national data analysis in South Korea

Abstract TMP44: Widening Sex Disparity in Thrombolysis Amid Worsening Stroke Care Quality in Korea

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015

Epidemiology of Venous Thromboembolism and Treatment Pattern of Oral Anticoagulation in Korea, 2009–2016: a Nationwide Study Based on the National Health Insurance Service Database

Sex differences in the applicability of Western cardiovascular disease risk prediction equations in the Asian population

National trend of the treatment for chronic venous diseases in Korea between 2010 and 2020

[Analysis of Activated Protein C Resistance, Factor V Coagulation Activity and Gene Polymorphisms in Patients with Venous Thromboembolism].

Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review

Cardiocerebrovascular Disease or Fatty Liver Incidence Associated with Pattern of Metabolic Risk Factors and Nutritional Status of Korean Adults: A Prospective Cohort Study

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

Sex Differences in Cardiovascular Disease Risk Factors among Korean Adults

A Survey of 20 Inherited Protein C Deficiencies in the Patients with Venous Thromboembolism

Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

Incidence and risk of stroke in Korean patients with congenital heart disease

A-217 Estimation of the Prevalence and the Patterns of Dyslipidemia in the Korean population

Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population

A-216 Prevalence and status of Lipoprotein(a) in the Korean population visiting local clinics and hospitals